Alan Skarbnik, MD, presents the case of a 60-year-old man with newly diagnosed follicular lymphoma.
A 60-Year-Old Man with Newly Diagnosed Follicular Lymphoma
A key opinion leader discusses the considerations in choosing induction and maintenance therapy options for follicular lymphoma.
Dr. Alan Skarbnik reviews the use of obinutuzumab-based therapies for follicular lymphoma and highlights data from a phase III study.
An expert describes typical monitoring strategies in follicular lymphoma.
Alan Skarbnik, MD, explains early relapse in follicular lymphoma and the available treatment options.
An oncologist ruminates on emerging treatment options in follicular lymphoma and offers some clinical pearls.
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma
4
Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma
5
